In-Silico Evaluation, Chemical Reactivity, and Covalent Docking Study of Various Quinazolines and Pyridopyrimidines as Inhibitors for the Epidermal Growth Factor Receptor

[1]  D. Harkati,et al.  A computational study of potent series of selective estrogen receptor degraders for breast cancer therapy , 2022, Journal of biomolecular structure & dynamics.

[2]  S. Çelik,et al.  Structural and vibrational investigations and molecular docking studies of a vinca alkoloid, vinorelbine , 2022, Journal of biomolecular structure & dynamics.

[3]  Hadjer Khelfaoui,et al.  In Silico Pesticide Discovery for New Anti-Tobacco Mosaic Virus Agents: Reactivity, Molecular Docking, and Molecular Dynamics Simulations , 2022, Applied Sciences.

[4]  S. Çelik,et al.  Vibrational spectroscopic characterization and structural investigations of Cepharanthine, a natural alkaloid , 2022, Journal of Molecular Structure.

[5]  S. A. E. El Bialy,et al.  Homology modelling, molecular dynamics simulation and docking evaluation of β-tubulin of Schistosoma mansoni. , 2021, Biophysical Chemistry.

[6]  A. Emwas,et al.  Practical and Computational Studies of Bivalence Metal Complexes of Sulfaclozine and Biological Studies , 2021, Frontiers in Chemistry.

[7]  Mubarak A. Alamri,et al.  Discovery of anti-MERS-CoV small covalent inhibitors through pharmacophore modeling, covalent docking and molecular dynamics simulation , 2021, Journal of Molecular Liquids.

[8]  S. Cho,et al.  Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation , 2020, Scientific Reports.

[9]  Xiaoqing Wang,et al.  Computational Approaches in Preclinical Studies on Drug Discovery and Development , 2020, Frontiers in Chemistry.

[10]  Hadjer Khelfaoui,et al.  Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2 , 2020, Journal of biomolecular structure & dynamics.

[11]  Mahmi Fujimori,et al.  Synthesis, theoretical calculation and anticancer activity of 4,6-diacetylresorcinol-dithiocarbazates and their Copper(II) complexes , 2020 .

[12]  Ruby Srivastava.  Chemical reactivity theory (CRT) study of small drug-like biologically active molecules , 2020, Journal of biomolecular structure & dynamics.

[13]  W. Liu,et al.  Covalent Inhibition in Drug Discovery , 2019, ChemMedChem.

[14]  M. Izadyar,et al.  Drug–DNA interaction, a joint DFT-D3/MD study on safranal as an anticancer and DNA nanostructure model , 2019, Canadian Journal of Chemistry.

[15]  A. K. Srivastava,et al.  Molecular Structures, Vibrational Spectra, Electronic Properties, and Molecular Docking of Two Pyrazoline Derivatives Containing 1-Carboxamide and 1-Carbothioamide: A Comparative Study , 2017 .

[16]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[17]  Shuhang Wang,et al.  EAI045: The fourth-generation EGFR inhibitor overcoming T790M and C797S resistance. , 2017, Cancer letters.

[18]  Diego Prada-Gracia,et al.  Application of computational methods for anticancer drug discovery, design, and optimization , 2016, Boletín Médico Del Hospital Infantil de México (English Edition).

[19]  J. A. Spicer,et al.  Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family. , 2016, Journal of medicinal chemistry.

[20]  L. Domingo,et al.  Applications of the Conceptual Density Functional Theory Indices to Organic Chemistry Reactivity , 2016, Molecules.

[21]  V. Loiko,et al.  Molecular structure and UV–Vis spectral analysis of new synthesized azo dyes for application in polarizing films , 2016 .

[22]  Haikuo Zhang,et al.  Overcoming EGFR T790M and C797S resistance with mutant-selective allosteric inhibitors , 2016 .

[23]  A. Cavalli,et al.  Role of Molecular Dynamics and Related Methods in Drug Discovery. , 2016, Journal of medicinal chemistry.

[24]  Deepak Dalvie,et al.  Discovery of 1-{(3R,4R)-3-[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants. , 2016, Journal of medicinal chemistry.

[25]  Jennifer L. Knight,et al.  OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. , 2016, Journal of chemical theory and computation.

[26]  Soumendranath Bhakat,et al.  Theory and Applications of Covalent Docking in Drug Discovery: Merits and Pitfalls , 2015, Molecules.

[27]  Che-Lun Hung,et al.  Computational Approaches for Drug Discovery , 2014, Drug development research.

[28]  A. J. Ahamed,et al.  Synthesis, Antimicrobial, and Anti-HIV1 Activity of Quinazoline-4(3H)-one Derivatives , 2013 .

[29]  Hai‐Liang Zhu,et al.  Synthesis, biological evaluation and molecular docking of novel 5-phenyl-1H-pyrazol derivatives as potential BRAF(V600E) inhibitors. , 2013, Organic & biomolecular chemistry.

[30]  A. Radwan,et al.  Synthesis and pharmacophore modeling of novel quinazolines bearing a biologically active sulfonamide moiety , 2013, Acta pharmaceutica.

[31]  Jie Shen,et al.  admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties , 2012, J. Chem. Inf. Model..

[32]  Carolina Pasa Vianna,et al.  Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations , 2012, Journal of Molecular Modeling.

[33]  B. A. Saleh.  Quantum chemical studies on para-substituted styrenyl fullerene. Study of substitution effects on structural and electronic properties , 2009 .

[34]  Haizhen Zhong,et al.  Induced-fit docking studies of the active and inactive states of protein tyrosine kinases. , 2009, Journal of molecular graphics & modelling.

[35]  Teodorico C. Ramalho,et al.  Construction and Assessment of Reaction Models of Class I EPSP Synthase: Molecular Docking and Density Functional Theoretical Calculations , 2009, Journal of biomolecular structure & dynamics.

[36]  P. Chattaraj,et al.  Comparison of Global Reactivity Descriptors Calculated Using Various Density Functionals: A QSAR Perspective. , 2009, Journal of chemical theory and computation.

[37]  M. Behalo.  Synthesis and Antimicrobial Activities of Some Novel Pyrido[2,3- d ]pyrimidine Derivatives , 2008 .

[38]  L. Domingo,et al.  A further exploration of a nucleophilicity index based on the gas-phase ionization potentials , 2008 .

[39]  C. Venugopal,et al.  Beta-secretase: structure, function, and evolution. , 2008, CNS & neurological disorders drug targets.

[40]  M. Meyerson,et al.  The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP , 2008, Proceedings of the National Academy of Sciences.

[41]  Maurizio Recanatini,et al.  Target-related applications of first principles quantum chemical methods in drug design. , 2006, Chemical reviews.

[42]  John Mendelsohn,et al.  Epidermal growth factor receptor targeting in cancer. , 2006, Seminars in oncology.

[43]  G. Klebe.  Virtual ligand screening: strategies, perspectives and limitations , 2006, Drug Discovery Today.

[44]  A. Gazdar,et al.  Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers , 2006, International journal of cancer.

[45]  William C Hahn,et al.  Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants , 2005, PLoS medicine.

[46]  Didier Rognan,et al.  Comparative evaluation of eight docking tools for docking and virtual screening accuracy , 2004, Proteins.

[47]  Wei-Jing Zhu,et al.  Surface energetics of hydroxyapatite: a DFT study , 2004 .

[48]  S. Gabriel,et al.  EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.

[49]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[50]  D. W. Fry,et al.  CI-1033, an irreversible pan-erbB receptor inhibitor and its potential application for the treatment of breast cancer. , 2003, Seminars in oncology.

[51]  H. van de Waterbeemd,et al.  ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.

[52]  Gisbert Schneider,et al.  Protein-ligand interactions from molecular recognition to drug design , 2003 .

[53]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[54]  J. Aihara,et al.  Reduced HOMO−LUMO Gap as an Index of Kinetic Stability for Polycyclic Aromatic Hydrocarbons , 1999 .

[55]  A. Becke.  Density-functional thermochemistry. V. Systematic optimization of exchange-correlation functionals , 1997 .

[56]  M. Karplus,et al.  Simulation of activation free energies in molecular systems , 1996 .

[57]  M. Klein,et al.  Constant pressure molecular dynamics algorithms , 1994 .

[58]  M. Klein,et al.  Nosé-Hoover chains : the canonical ensemble via continuous dynamics , 1992 .

[59]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[60]  D. Glossman-Mitnik,et al.  A fast and simple evaluation of the chemical reactivity properties of the Pristinamycin family of antimicrobial peptides , 2020 .

[61]  J. Shih,et al.  ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. , 2013, Cancer letters.

[62]  Claude Le Bris,et al.  Mathematical models and methods for ab initio quantum chemistry , 2000 .